NanoEcho as investment

Addresses an unmet medical need

50% global growth by 2030

Reduce healthcare costs and improve quality of life

An experienced team with a proven technique

Reports

Owners

10 largest owners per 2022-12-31

Owners Holdings Votes in %
MTT CAPITAL AB
2.446.043
8,14
NILSSON, SETH MARTIN FREDRIK
1.784.621
5,94
WINGOLF, JONAS THEODOR
1.758.584
5,85
QUIQ HOLDING AB
1.666.667
5,54
JENSEN, TORSTEN ROGER
1.188.600
3,95
NORDNET PENSIONSFÖRSÄKRING AB
1.064.939
3,54
JANSSON, TOMAS
999.746
3,33
CLOUDO AB
782.366
2,60
VIRTWAY INVEST AB
743.582
2,47
KOGAI INVEST AB
590.000
1,96
OTHER
17.037.985
56,67
TOTAL
30.063.133
100

Owners

NORDNET PENSIONSFÖRSÄKRING AB
MTT CAPITAL AB
NILSSON, SETH MARTIN FREDRIK
WINGOLF, JONAS THEODOR
QUIQ HOLDING AB
JENSEN, TORSTEN ROGER
VIRTWAY INVEST AB
JANSSON, TOMAS
CLOUDO AB
KOGAI INVEST AB

Others

TOTAL

Holdings

2.755.669
2.446.043
1.784.621
1.758.584
1.666.667
1.188.600
1.012.240
999.746
782.366
590.000
14.984.536


30.063.133

Votes in %

9,17
8,14
5,94
5,85
5,54
3,95
3,37
3,33
2,60
1,96
49,84


100

Financial calendar

Årsredovisning 2021
Kvartalsrapport 1
Kvartalsrapport 2
Kvartalsrapport 3
Bokslutskommuniké
Årsredovisning för 2022
Kvartalsrapport 1
Halvårsrapport 2
Kvartalsrapport 3
2022-04-11
2022-04-28
2022-08-23
2022-10-26
2023-02-08
2023-04-12
2023-04-27
2023-08-23
2023-10-26

References

  • Sjöstrand S et. al. Magnetomotive Ultrasound Imaging Systems: Basic Principles and First Applications, Ultrasound Med Biol, Volume 46, (2020), Issue 10
  • Oh J et. al. Detection of magnetic nanoparticles in tissue using magneto-motive ultrasound, Nanotechnology, 17 (2006)
  • Evertsson M et. al. Combined Magnetomotive ultrasound, PET/CT, and MR imaging of 68 Ga-labelled superparamagnetic iron oxide nanoparticles in rat sentinel lymph nodes in vivo. Scientific reports 7.1 (2017): 1-9
  • Evertsson M et. al. Multimodal detection of iron oxide nanoparticles in rat lymph nodes using Magnetomotive ultrasound imaging and Magnetic Resonance Imaging, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control,  vol 61, no.8, pp 1276-1283, 2014.
  • Johnson L et. al. Deposition of Superparamagnetic Iron-Oxide Nanoparticles in Axillary Sentinel Lymph Nodes Following Subcutaneous Injection, Histopathology 62 (2013)
  • Ghilli M et. al. The superparamagnetic iron oxide tracer: a valid alternative in sentinel node biopsy for breast cancer treatment. European journal of cancer care 26.4 (2017): e12385.
  • Qiao R et. al. Superparamagnetic iron oxide nanoparticles: from preparations to in vivo MRI applications, J Mat Chem, 19 (2009)
  • Arnold M et. al. Global patterns and trends in colorectal cancer incidence and mortality Gut. 01 april 2017;66(4)
  • Thorlacius H and Toth E, Screening för kolorektal cancer – evidensläge, metoder och utmaningar Läkartidningen vol 115
  • Thorlacius H et. al. Endoskopisk dissektion av submukosa vid kolorektala polyper, Läkartidningen, 2012;45
  • Srisajjakul S et. al. Pitfalls in MRI of rectal cancer: What radiologists need to know and avoid. Clinical imaging. 2017;50
  • Siddiqui MRS et. al. A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases. British journal of cancer. 2017.
  • de Jong EA et. al. The accuracy of MRI, endorectal ultrasonography, and computed tomography in predicting the response of locally advanced rectal cancer after preoperative therapy: A metaanalysis. Surgery. 2016;159(3)
  • Rönnow CF et. al. Lymphovascular Infiltration, Not Depth of Invasion, is the Critical Risk Factor of Metastases in Early Colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, Including Validation Annals of Surgery. March 13, 2020
  • Mehta, S J et. al.  Colorectal Cancer Screening Starting at Age 45 Years — Ensuring Benefits Are Realized by All JAMA Network Open. 2021;4(5):e2112593. doi:10.1001/jamanetwork

  • Evertsson, Maria, et al. Combined Magnetomotive ultrasound, PET/CT, and MR imaging of 68 Ga-labelled superparamagnetic iron oxide nanoparticles in rat sentinel lymph nodes in vivo, Scientific reports 7.1 (2017): 1-9
  • O’Donnell M Magnetic nanoparticles as contrast agents for molecular imaging in medicine, Physica C, 548 (2018)
  • Levy B E et. al. Effect of model thrombus volume and elastic modulus on magnetomotive ultrasound signal under pulsatile flow, IEEE Trans Ultrason Ferroelectr Freq Control, 65 (2018)
  • Fink M et. al. Influence of naturally occurring tissue movements on magnetomotive ultrasound detection of iron oxide nanoparticles for magnetic drug targeting, 2017 IEEE International Ultrasonics Symposium (IUS)
  • Santiesteban DY et. al.  Monitoring/Imaging and Regenerative Agents for Enhancing Tissue Engineering Characterization and Therapies, Annals of Biomedical Engineering, 21 Dec 2015, 44(3)

The share

NanoEcho is a reconciliation company and its shares are registered in electronic form with Euroclear Sweden AB, where its share register is also kept. All shares are of the same type, have equal rights to share in the company’s assets and profits and have the same voting value. All shares are issued and fully paid.

Shares AK

Number of shares: 30.063.133
ISIN: SE0013775566
LEI: 894500C46ZR7PVT2LU02

Investor relations

Contact

Kristina Hallström
CCO/CMO
E-mail: ir@nanoecho.se

Nanoecho.se använder cookies för att förbättra hemsidans funktionalitet för dig som användare. Är det okej?